Share on LinkedInShare on LinkedIn

ARTICLE · 18 JANUARY 2011

OSC Rejects Deference to Target Boards in Poison Pill Decisions

Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
Contributor
Borden Ladner Gervais LLP

Borden Ladner Gervais LLP

With over 750 lawyers, intellectual property agents and other professionals, BLG services...

View firm profile
Explore more from Borden Ladner Gervais LLP

The Ontario Securities Commission’s reasons in "Baffinland Iron Mines Corporation" clearly rejected the proposition that securities commissions should defer to the business judgment of a target board of directors in deciding whether to cease trade a shareholder rights plan (also known as a poison pill).

CanadaCorporate/Commercial Law

The Ontario Securities Commission's reasons in Baffinland Iron Mines Corporation clearly rejected the proposition that securities commissions should defer to the business judgment of a target board of directors in deciding whether to cease trade a shareholder rights plan (also known as a poison pill). This decision should clarify some of the confusion arising from the OSC's earlier decision in Neo Material Technologies Inc. and the British Columbia Securities Commission's decision in Lions Gate Entertainment Corp.

The Baffinland Contest

Nunavut Iron Ore Acquistion Inc. made an unsolicited offer to acquire the shares of Baffinland on September 22, 2010, which resulted in a contest for control of Baffinland. On November 8, 2010, Baffinland entered into a support agreement in connection with a competing offer from ArcelorMittal S.A. The ArcelorMittal offer also had the support of Baffinland shareholders holding approximately 26% of the outstanding shares. Both offers

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from